2022 annual financial data
Processa Pharmaceuticals 2022 Revenue growth
Direct answer
Revenue growth was Not calculable.
Operating income was -20,257,288 USD and net income was -27,424,229 USD.
Operating cash flow was -9,605,143 USD.
Get free Processa Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -20,257,288 USD
- Net income
- -27,424,229 USD
- Operating cash flow
- -9,605,143 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Processa Pharmaceuticals financial years